Showing results (81-90 of 125) with videos related to
Sort By:
Pageof 13
Cancer Treatment Reports|December 1, 1983
Phase II study of amsacrine gluconate in refractory leukemiaG A Omura, E F Winton, W R Vogler, et al.Blood|May 1, 1984
A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trialW R Vogler, E F Winton, D S Gordon, et al.Biochemical and Biophysical Research Communications|March 15, 1989
Fluorimetric studies of protein kinase C interactions with phospholipidsJ M Rodriguez-Paris, M Shoji, S Yeola, et al.American Journal of Ophthalmology|December 25, 1991
Bone marrow transplant retinopathyP F Lopez, P Sternberg, C K Dabbs, et al.Lipids|February 1, 1991
Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cellsM Shoji, R L Raynor, E A Fleer, et al.Journal of Lipid Mediators|September 1, 1990
Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitroS Danhauser-Riedl, A Himmelmann, G Steinhauser, et al.American Journal of Clinical Oncology|February 1, 1992
Late intensification therapy in adult acute lymphoid leukemia. The Southeastern Cancer Study Group ExperienceO J Martelo, G A Omura, D S Gordon, et al.American Journal of Clinical Pathology|March 1, 1992
Large granular lymphocyte proliferation with the natural killer-cell phenotypeW C Chan, L B Gu, A Masih, et al.Cancer Research|December 1, 1987
Effects of phorbol ester on translocation and down-regulation of protein kinase C and phosphorylation of endogenous proteins in human acute myeloid leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1aM Shoji, P R Girard, P A Charp, et al.Leukemia Research|January 1, 1990
Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trialR S Stein, W R Vogler, E F Winton, et al.Pageof 13